NCT04282486View on ClinicalTrials.gov

Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease

CompletedOBSERVATIONAL
Enrollment

142

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

January 29, 2021

Study Completion Date

January 29, 2021

Conditions
Hemophilia
Interventions
OTHER

Telephone interview

"Primary objective: potentially inappropriate medication prevalence~Secondary objective:~Number and type of medication Polypharmacy prevalence Medication regimen complexity using Medication Regimen Complexity Index Anticholinergic and sedative exposure using Drug Burden Index~A telephone interview will be conducted with patients in order to collect medication data from medical prescriptions."

Trial Locations (1)

69100

Hôpital des Charpennes, Institut du Vieillissement, Villeurbanne

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT04282486 - Medication Exposure in Older Patients With Constitutional Hemorrhagic Disease | Biotech Hunter | Biotech Hunter